Dishman Pharmaceuticals & Chemicals has informed that the meeting of the Management Committee of Board of Directors of amalgamated entity i.e. Dishman Carbogen Amcis Limited (DCAL) [formerly known as Carbogen Amcis (India)] will be held on Friday, the 19th day of May, 2017 at 11:00 a.m. at Ahmedabad, to fix the Record Date for the purpose of deciding the members who shall be eligible for allotment of equity shares of Dishman Carbogen Amcis to the shareholders of Dishman Pharmaceuticals and Chemicals in the ratio of 1:1 i.e. Share Exchange Ratio, fixed under the Scheme of Merger approved by the Hon’ble High Court of Gujarat.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.50 |
| Dr. Reddys Lab | 1233.20 |
| Cipla | 1232.00 |
| Zydus Lifesciences | 937.70 |
| Lupin | 2327.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: